Literature DB >> 21444794

Retaining cell-cell contact enables preparation and culture of spheroids composed of pure primary cancer cells from colorectal cancer.

Jumpei Kondo1, Hiroko Endo, Hiroaki Okuyama, Osamu Ishikawa, Hiroyasu Iishi, Masahiko Tsujii, Masayuki Ohue, Masahiro Inoue.   

Abstract

Primary culture of the cancer cells from patients' tumors can provide crucial information of individual tumors, yet the technology has not been optimized until now. We developed an innovative culture method for primary colorectal cancer cells, based on the principle that cell-cell contact of cancer cells was maintained throughout the process. When tumor tissue was dissociated into cell clusters, in which cell-cell contact was retained, they rapidly formed spheroids that we termed cancer tissue-originated spheroids (CTOSs). CTOSs of colorectal cancer consisted of highly purified and viable cancer cells, and they were prepared with high efficiency. In immunodeficient mice, CTOSs formed xenograft tumors that retained the features of the parental tumors. Moreover, CTOSs were able to be cultured and expanded in vitro using a 3D culture system and stem cell culture medium. This method allowed evaluation of chemosensitivity and signal pathway activation in cancer cells from individual patients. Easy preparation and culture of pure primary cancer cells provides an innovative platform for studying cancer biology and developing personalized medicine.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21444794      PMCID: PMC3076886          DOI: 10.1073/pnas.1015938108

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  39 in total

Review 1.  Islet transplantation: lessons learned since the Edmonton breakthrough.

Authors:  R M Langer
Journal:  Transplant Proc       Date:  2010-06       Impact factor: 1.066

Review 2.  Exploiting the PI3K/AKT pathway for cancer drug discovery.

Authors:  Bryan T Hennessy; Debra L Smith; Prahlad T Ram; Yiling Lu; Gordon B Mills
Journal:  Nat Rev Drug Discov       Date:  2005-12       Impact factor: 84.694

Review 3.  The NCI60 human tumour cell line anticancer drug screen.

Authors:  Robert H Shoemaker
Journal:  Nat Rev Cancer       Date:  2006-10       Impact factor: 60.716

4.  E-cadherin cell-cell adhesion in ewing tumor cells mediates suppression of anoikis through activation of the ErbB4 tyrosine kinase.

Authors:  Hyung-Gyoo Kang; Jasmine M Jenabi; Jingsong Zhang; Nino Keshelava; Hiroyuki Shimada; William A May; Tony Ng; C Patrick Reynolds; Timothy J Triche; Poul H B Sorensen
Journal:  Cancer Res       Date:  2007-04-01       Impact factor: 12.701

Review 5.  The E-cadherin adhesion molecule and colorectal cancer. A global literature approach.

Authors:  Elena Tsanou; Dimitrios Peschos; Anna Batistatou; Alexandros Charalabopoulos; Konstantinos Charalabopoulos
Journal:  Anticancer Res       Date:  2008 Nov-Dec       Impact factor: 2.480

6.  KRAS mutation testing in the treatment of metastatic colorectal cancer with anti-EGFR therapies.

Authors:  D Soulières; W Greer; Anthony M Magliocco; D Huntsman; S Young; M-S Tsao; S Kamel-Reid
Journal:  Curr Oncol       Date:  2010-07       Impact factor: 3.677

7.  Matuzumab and cetuximab activate the epidermal growth factor receptor but fail to trigger downstream signaling by Akt or Erk.

Authors:  Takeshi Yoshida; Isamu Okamoto; Takafumi Okabe; Tsutomu Iwasa; Taroh Satoh; Kazuto Nishio; Masahiro Fukuoka; Kazuhiko Nakagawa
Journal:  Int J Cancer       Date:  2008-04-01       Impact factor: 7.396

Review 8.  PKB/Akt: a key mediator of cell proliferation, survival and insulin responses?

Authors:  M A Lawlor; D R Alessi
Journal:  J Cell Sci       Date:  2001-08       Impact factor: 5.285

9.  Cadherin-catenin expression in primary colorectal cancer: a survival analysis.

Authors:  T J Hugh; S A Dillon; B A Taylor; M Pignatelli; G J Poston; A R Kinsella
Journal:  Br J Cancer       Date:  1999-06       Impact factor: 7.640

10.  Newly characterised ex vivo colospheres as a three-dimensional colon cancer cell model of tumour aggressiveness.

Authors:  L-B Weiswald; S Richon; P Validire; M Briffod; R Lai-Kuen; F P Cordelières; F Bertrand; D Dargere; G Massonnet; E Marangoni; B Gayet; M Pocard; I Bieche; M-F Poupon; D Bellet; V Dangles-Marie
Journal:  Br J Cancer       Date:  2009-07-14       Impact factor: 7.640

View more
  125 in total

Review 1.  Human Colon Organoids and Other Laboratory Strategies to Enhance Patient Treatment Selection.

Authors:  Katherine A Johnson; Rebecca A DeStefanis; Philip B Emmerich; Patrick T Grogan; Jeremy D Kratz; Sarbjeet K Makkar; Linda Clipson; Dustin A Deming
Journal:  Curr Treat Options Oncol       Date:  2020-04-23

Review 2.  Tissue-engineered models of human tumors for cancer research.

Authors:  Aranzazu Villasante; Gordana Vunjak-Novakovic
Journal:  Expert Opin Drug Discov       Date:  2015-02-07       Impact factor: 6.098

3.  3D Tumor Spheroid Models for In Vitro Therapeutic Screening of Nanoparticles.

Authors:  Simonas Daunys; Agnė Janonienė; Indrė Januškevičienė; Miglė Paškevičiūtė; Vilma Petrikaitė
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

4.  KRAS mutations in the parental tumour accelerate in vitro growth of tumoroids established from colorectal adenocarcinoma.

Authors:  Nabi Mousavi; Sarah Line Bring Truelsen; Grith Hagel; Lars Nannestad Jorgensen; Henrik Harling; Vera Timmermans; Linea Cecilie Melchior; Anna Hammerich Thysen; Steffen Heegaard; Jacob Thastrup
Journal:  Int J Exp Pathol       Date:  2019-03-18       Impact factor: 1.925

5.  Discovery and Structure-Based Optimization of Potent and Selective WD Repeat Domain 5 (WDR5) Inhibitors Containing a Dihydroisoquinolinone Bicyclic Core.

Authors:  Jianhua Tian; Kevin B Teuscher; Erin R Aho; Joseph R Alvarado; Jonathan J Mills; Kenneth M Meyers; Rocco D Gogliotti; Changho Han; Jonathan D Macdonald; Jiqing Sai; J Grace Shaw; John L Sensintaffar; Bin Zhao; Tyson A Rietz; Lance R Thomas; William G Payne; William J Moore; Gordon M Stott; Jumpei Kondo; Masahiro Inoue; Robert J Coffey; William P Tansey; Shaun R Stauffer; Taekyu Lee; Stephen W Fesik
Journal:  J Med Chem       Date:  2020-01-07       Impact factor: 7.446

6.  Comparing Single Cell Versus Pellet Encapsulation of Mesenchymal Stem Cells in Three-Dimensional Hydrogels for Cartilage Regeneration.

Authors:  Heather Rogan; Francisco Ilagan; Fan Yang
Journal:  Tissue Eng Part A       Date:  2019-05-02       Impact factor: 3.845

Review 7.  Three-dimensional cell culture systems and their applications in drug discovery and cell-based biosensors.

Authors:  Rasheena Edmondson; Jessica Jenkins Broglie; Audrey F Adcock; Liju Yang
Journal:  Assay Drug Dev Technol       Date:  2014-05       Impact factor: 1.738

8.  Cancer Stem Cell-Based Models of Colorectal Cancer Reveal Molecular Determinants of Therapy Resistance.

Authors:  Maria Laura De Angelis; Ann Zeuner; Eleonora Policicchio; Giorgio Russo; Alessandro Bruselles; Michele Signore; Sara Vitale; Gabriele De Luca; Emanuela Pilozzi; Alessandra Boe; Giorgio Stassi; Lucia Ricci-Vitiani; Carla Azzurra Amoreo; Alfredo Pagliuca; Federica Francescangeli; Marco Tartaglia; Ruggero De Maria; Marta Baiocchi
Journal:  Stem Cells Transl Med       Date:  2016-03-08       Impact factor: 6.940

9.  In vitro organoid culture of primary mouse colon tumors.

Authors:  Xiang Xue; Yatrik M Shah
Journal:  J Vis Exp       Date:  2013-05-17       Impact factor: 1.355

10.  Spheroid culture of LuCaP 147 as an authentic preclinical model of prostate cancer subtype with SPOP mutation and hypermutator phenotype.

Authors:  Matthias Saar; Hongjuan Zhao; Rosalie Nolley; Sarah R Young; Ilsa Coleman; Peter S Nelson; Robert L Vessella; Donna M Peehl
Journal:  Cancer Lett       Date:  2014-07-03       Impact factor: 8.679

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.